GustavoSchvartsmanMD

Physician

Dr. Schvartsman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

170 citations
Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer.
Gustavo Schvartsman, S. Andrew Peng, Giorgios Bis, J. Jack Lee, Marcelo F. Benveniste
Lung Cancer. 2017-10-01
39 citations
Immune Checkpoint Inhibitor Therapy in a Liver Transplant Recipient With Melanoma
Gustavo Schvartsman, Kristen Perez, Gagan Sood, Riham Katkhuda, Hussein Abdul-Hassan Tawbi
Annals of Internal Medicine. 2017-09-05
18 citations
Safe and effective administration of T-VEC in a patient with heart transplantation and recurrent locally advanced melanoma.
Gustavo Schvartsman, Kristen Perez, Jill E. Flynn, Jeffrey N. Myers, Hussein Abdul-Hassan Tawbi
Journal for Immunotherapy of Cancer. 2017-06-20

Lectures

Outcomes of metastatic melanoma (MM) patients (pts) after discontinuation of anti-Programmed-Death 1 (PD1) therapy without disease progression.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
A phase II study of study of bevacizumab (BEV) in combination with atezolizumab (ATEZO) in pts (pts) with untreated melanoma brain metastases (BEAT-MBM).
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018